Parallax Diagnostics Announces Intent to Develop a Rapid Screening Test for COVID-19 on its Patented FDA 510(K) Approved Diagnostic Platform
March 11, 2020 07:00 ET
|
Parallax Health Sciences, Inc.
Company will Partner to Accelerate The Deployment of Diagnostic Solutions Under Patent Protected Service Areas Including China, Hong Kong, India, and US NEW YORK, NY, March 11, 2020 (GLOBE...
Parallax Provides Mid-Quarter Update
February 24, 2020 07:00 ET
|
Parallax Health Sciences, Inc.
Company Eliminates $25 Million Contingent Liability and Focuses Toward Operating Growth Parallax Licensing Program Moving Forward on All Fronts NEW YORK, NY, Feb. 24, 2020 (GLOBE NEWSWIRE) -- via...
Parallax Good Health Outcomes Mobile Application for Remote Patient Monitoring Now Available to Over 300,000 Patients in North America Through Existing Agreements
February 10, 2020 07:00 ET
|
Parallax Health Sciences, Inc.
Critical Access Hospitals, Doctor Offices and Nursing Operations Contract with Parallax for Chronic Disease Management Capitalizing on New Reimbursement Landscape NEW YORK, NY, Feb. 10, 2020 (GLOBE...
Parallax Health Sciences Announces Patent Enforcement Initiative
January 06, 2020 07:00 ET
|
Parallax Health Sciences, Inc.
Over $500 Million in Potential Infringement Damages Present in Diagnostic and Behavioral Markets NEW YORK, NY, Jan. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences,...
Parallax Health Sciences Engages Alston & Bird
January 02, 2020 07:00 ET
|
Parallax Health Sciences, Inc.
New York, NY, Jan. 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax”), an outcome-driven connected healthcare company, today announced that it...
Parallax Health Sciences Reports Third Quarter 2019 Financial Results
November 18, 2019 06:00 ET
|
Parallax Health Sciences, Inc.
SANTA MONICA, Calif., Nov. 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax”), an outcome-driven connected healthcare company, reports...
Parallax Behavioral Health Achieves Data Driven Outcomes Adoption and Vertical Market Integration
November 12, 2019 08:00 ET
|
Parallax Health Sciences, Inc.
SANTA MONICA, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare...
Parallax Health Sciences Announces Acquisition of Minority Interest In Global Career Networks
September 19, 2019 13:18 ET
|
Parallax Health Sciences, Inc.
SANTA MONICA, CA, Sept. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare...
Parallax Health Sciences Reports Second Quarter 2019 Financial Results
August 20, 2019 06:00 ET
|
Parallax Health Sciences, Inc.
SANTA MONICA, Calif., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax”), an outcome-driven connected healthcare company, reports financial results for June...
Parallax Health Sciences Announces Licensing Agreement With HealthPointe Solutions
July 18, 2019 10:23 ET
|
Parallax Health Sciences, Inc.
Cognitive Artificial Intelligence and Data Analytics Combined with Outcomes Optimization for the Healthcare Market SANTA MONICA, CA, July 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax...